MedPath

信合援生制药股份有限公司

Ownership
-
Established
1989-10-20
Employees
-
Market Cap
-
Website
www.yshmc.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

168

NMPA:168

Drug Approvals

金银花露

Approval Number
国药准字Z41022358
Approval Date
Apr 21, 2025
NMPA

Isoniazid Injection

Product Name
异烟肼注射液
Approval Number
国药准字H20258063
Approval Date
Apr 10, 2025
NMPA

精制冠心颗粒

Approval Number
国药准字Z10960084
Approval Date
Nov 20, 2023
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20233765
Approval Date
Jun 21, 2023
NMPA

Dextran 40 Sodium Chloride Injection

Product Name
右旋糖酐40氯化钠注射液
Approval Number
国药准字H41022582
Approval Date
Sep 19, 2022
NMPA

Compound Amino Acid Injection(17AA)

Product Name
复方氨基酸注射液(17AA)
Approval Number
国药准字H19993685
Approval Date
Sep 19, 2022
NMPA

Dextran 40 Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H41022584
Approval Date
Sep 19, 2022
NMPA

Compound Amino Acid Injection (14AA)

Product Name
复方氨基酸注射液(14AA)
Approval Number
国药准字H19993534
Approval Date
Sep 19, 2022
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H41025381
Approval Date
Sep 19, 2022
NMPA

Compound Amino Acid Injection (15AA)

Product Name
复方氨基酸注射液(15AA)
Approval Number
国药准字H19993535
Approval Date
Sep 19, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.